Pulmonx (LUNG) Current Assets (2019 - 2025)

Pulmonx (LUNG) has reported Current Assets for 7 consecutive years, with $101.7 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Current Assets fell 25.37% year-over-year to $101.7 million in Q4 2025; TTM through Dec 2025 was $101.7 million, a 25.37% decrease from a year earlier, with the FY2025 full-year figure at $101.7 million, down 25.37% from the prior year.
• Current Assets was $101.7 million for Q4 2025 at Pulmonx, down from $111.2 million in the prior quarter.
• Over five years, Current Assets peaked at $239.3 million in Q1 2021 and troughed at $101.7 million in Q4 2025.
• A 5-year average of $166.3 million and a median of $157.4 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 309.27% in 2021 and dropped 25.37% in 2025, its largest moves.
• Over 5 years, Current Assets stood at $208.0 million in 2021, then fell by 18.77% to $169.0 million in 2022, then decreased by 10.97% to $150.4 million in 2023, then slipped by 9.42% to $136.2 million in 2024, then dropped by 25.37% to $101.7 million in 2025.
• The last three Current Assets figures came in at $101.7 million (Q4 2025), $111.2 million (Q3 2025), and $120.0 million (Q2 2025), per Business Quant data.